Navigation Links
White House Healthcare Summit Offers Opportunity for Input Into Reform
Date:3/12/2009

WASHINGTON, March 12 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement regarding the White House health reform summit in Dearborn, Michigan today:

"Michigan has been given an historic opportunity to help offer solutions to the healthcare crisis we are now facing in the U.S. Through a series of White House health reform summits taking place in Dearborn and other cities across the country over the next two months, a diverse group of stakeholders - including patients, physicians, industry, labor and government - will be openly discussing key elements needed in a comprehensive healthcare reform package. These discussions are critical to help ensure that healthcare reform remains a top national priority this year and does not fall by the wayside.

"Finding common ground to address weaknesses in our healthcare system is our mission, but so too is building on our many great healthcare strengths. For this reason, we should celebrate the fact that America remains the world leader in the innovation of new technologies and medical advances.

"The fact that more than 750 new medicines and vaccines are in development for cancer by America's pharmaceutical research and biotechnology companies is just one reason that our country is at the epicenter of scientific and medical advances that can greatly improve the health of millions of patients suffering from this life-threatening disease, including the nearly 360,000 Wolverine patients suffering from cancer. Clearly, important work is already underway to help find a cure for cancer, a top priority for President Obama.

"The engines of innovation - such as America's biopharmaceutical companies - are deeply vested in improving the health of patients worldwide and contribute significantly to the U.S. economy by helping create millions of jobs. Last year alone, America's pharmaceutical companies invested a record $65.2 billion researching and developing new medicines and cures. And, more than 3.2 million jobs were supported by the biopharmaceutical sector in 2006. For this reason, it is critical, now more than ever, that lawmakers support policies that promote job stability in all sectors and strengthen innovation of new medical advances.

"While medicines and vaccines offer hope to millions of patients in America suffering from disease, they are meaningless if they remain out of reach to the patients who need them most. For this reason, all Americans should have access to high-quality and affordable healthcare coverage. Co-pays and other cost-sharing must also be affordable to help ensure that patients can get access to the health care services and prescription medicines they need to better fight their disease.

"We must also transform our sick-care system to a 21st century healthcare system that focuses on disease prevention and management to help keep patients out of the hospital and most importantly, help keep Americans from getting sick in the first place. To that end, we must do more to prevent chronic disease in America. Chronic disease is the number one killer and top health care cost driver in the U.S., with 75 cents of every healthcare dollar going to treat these diseases. More than six million cases of seven common chronic diseases such as cancer, hypertension and diabetes were reported in the Wolverine state and lost workdays and lower productivity as a result of chronic disease led to economic loss due in Michigan of $37.9 billion in 2003, according to the Milken Institute.

"Clearly, there is a lot of work that needs to be done to help ensure that a meaningful and comprehensive healthcare reform package gets on the President's desk this year. But if we all continue to work together and have open and honest dialogue to help find common ground, we can certainly make that happen."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the dangers of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ability to cope with stress can increase good cholesterol in older white men, study finds
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
5. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
6. Older blacks and Latinos still lag whites in controlling diabetes
7. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
8. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
9. Marian Jones Should Return Olympic Medals, Says Ex-White House Drug Spokesman Bob Weiner
10. Whites take supplemental breast cancer therapy more often than blacks
11. Differences observed between black and white women in use of breast cancer therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... 2017 , ... After a summer-long contest to crown the ... Drivers proudly announced the winners of the HEROtini Mocktail Challenge at the Stockton ... the challenge of competing in three categories: Best HEROtini Mocktail, Top HEROtini Bartender, ...
(Date:9/26/2017)... ... , ... Data Integrity: , The Key to FDA and GMP Compliance, ** ... http://www.fdanews.com/fdadataintegrity , Consider this situation. The FDA gives simple ... be trustworthy and reliable … a more detailed evaluation may be warranted.” , ...
(Date:9/26/2017)... ... 26, 2017 , ... Dr. Kovatis, is a Hospital for ... and Foot Section of the Department of Orthopedic Surgery at Hackensack University Medical ... UMC performing total ankle replacements. Because of this, Dr. Kovatis is often referred ...
(Date:9/26/2017)... , ... September 26, 2017 , ... The 2017 American ... called “The Magic of Fat,” revealed not only the latest about cosmetic procedures to ... be an evolution in cosmetic medicine. , “Fat really is magical, especially when it ...
(Date:9/26/2017)... ... 26, 2017 , ... The Organizing Committee is pleased to ... Pittcon 2018. As of July 1, Adrian C. Michael, Ph.D. (University of Pittsburgh, ... Charles Gardner, (ChemImage Corporation) and selected chairs. , Other members of ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)...  Eli Lilly and Company (NYSE: ... to more efficiently focus resources on developing new ... workforce reductions, including those from a U.S. voluntary ... 3,500 positions. With the streamlining ... approximately $500 million that will begin to be ...
Breaking Medicine Technology: